The NPSA welcomes today’s release of the Discussion Paper – Review of Pharmacy Remuneration and Regulation. This Paper comprehensively explores the operation of all aspects of the supply chain, from manufacturers to consumers. While many of the questions posed might be controversial, the process itself should be able to examine all these issues in a methodical and reasonable manner.
According to Donna Staunton, spokesperson for the NPSA, “The Discussion Paper has raised all the issues that are of concern to wholesalers. We look forward to deepening our engagement with the review process to ensure that Australia has a viable and sustainable pharmaceutical wholesaling sector into the future,” she said.
“Australia’s system of pharmaceutical wholesaling ensures rapid and equitable access to pharmaceuticals across Australia, no matter who you are or where you live. This notion of timely access to medicines is a central pillar of Australia’s National Medicines Policy,” she added.
Contact: Donna Staunton on 0413 185 724 or Donna Edman on 0419 850 174